Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FIGO Stages II to IV”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Large-scale testing (Phase 3)Study completedNCT00006454
What this trial is testing

Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer

Who this might be right for
Fallopian Tube CancerOvarian Cancer
AGO Study Group
Testing effectiveness (Phase 2)Study completedNCT00880360
What this trial is testing

A Trial of Intravenous Denileukin Diftitox in Stage III or IV Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerExtraovarian Peritoneal CancerFallopian Tube Carcinoma
The University of Texas Health Science Center at San Antonio 19
Testing effectiveness (Phase 2)UnknownNCT00551577
What this trial is testing

Neoadjuvant Chemotherapy With Carboplatin and Docetaxel in Patients With Advanced Ovarian Cancer-Prospective, Randomized Phase II Clinical Trial

Who this might be right for
Ovarian Neoplasms
University Hospital, Bonn 100
Testing effectiveness (Phase 2)Ended earlyNCT01773889
What this trial is testing

A Trial of Intravenous Denileukin Diftitox Plus Subcutaneous Pegylated IFNα-2A in Stage III or IV Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerExtraovarian Peritoneal CancerFallopian Tube Carcinoma
The University of Texas Health Science Center at San Antonio 2
Large-scale testing (Phase 3)UnknownNCT02159820
What this trial is testing

Lower Dose Decitabine (DAC)-Primed TC (Carboplatin-Paclitaxel) Regimen in Ovary Cancer

Who this might be right for
Primary Malignant Neoplasm of OvaryFIGO Stages II to IV
Chinese PLA General Hospital 500
Testing effectiveness (Phase 2)UnknownNCT06377267
What this trial is testing

Status of HRD That Lead to a Benefit From Olaparib in Combination With Bevacizumab (STROBE Trial)

Who this might be right for
Ovarian Cancer
Vall d'Hebron Institute of Oncology 100
Testing effectiveness (Phase 2)Study completedNCT00281515
What this trial is testing

Comparison of Paclitaxel/Carboplatin and Lonafarnib to Paclitaxel/Carboplatin for First-line Treatment of Ovarian Cancer

Who this might be right for
Epithelial Ovarian Cancer
AGO Study Group 105